GLP-1 therapy benefits men experiencing metabolic changes and stubborn weight gain
On Monday, the Food and Drug Administration approved a pill version of Wegovy, Novo Nordisks wildly popular weight loss drug, officially launching the first oral GLP-1 medication ever cleared for obesity treatment
Lancet 406 , 149162 (2025)
Records should include current weight, BMI, weight history, diagnoses, and relevant comorbid conditions
The potential HF benefit associated with better kidney function may in part also be due to improved haemodynamic parameters that essentially relieve the failing heart of stress factors and workload
The increase in cAMP levels in -cells is a consequence of GLP-1R activation in these cells, which in turn enhances the secretion of growth inhibitory hormone through signaling pathways such as PKA and Calcium/Calmodulin-dependent protein kinase (Brereton et al., 2015)